Stock Events

Stock Events

Sihuan Pharmaceutical Group 

$4.40
8
+$1.64+59.82% Tuesday 20:00

Statistics

Day High
-
Day Low
-
52W High
4.4
52W Low
4.36
Volume
-
Avg. Volume
62
Mkt Cap
41.01B
P/E Ratio
-
Dividend Yield
1.27%
Dividend
0.06

Upcoming

Dividends

1.27%Dividend Yield
Jul 26
$0.06
Oct 25
$0.06
Oct 24
$0.11
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
-0.74%

Earnings

26AugExpected
Q1 2021
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0
0
0
0.01
Expected EPS
N/A
Actual EPS
0.003664782

Financials

6.84%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
370.38MRevenue
25.34MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SHPHY. It's not an investment recommendation.
JPMorgan Chase
3
JPM
Walmart
3
WMT
Apple
2
AAPL
Apple
2
APC.XETRA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GSK
GSK
Mkt Cap104.97B
GlaxoSmithKline is a global healthcare company that competes in various pharmaceutical sectors, including areas where Sihuan Pharmaceutical operates.
Pfizer
PFE
Mkt Cap159.99B
Pfizer is a large pharmaceutical company with a broad range of products that compete in the same market segments as Sihuan Pharmaceutical.
Novartis
NVS
Mkt Cap301.95B
Novartis is a global healthcare company that offers products in multiple areas, including those where Sihuan Pharmaceutical is active, making it a direct competitor.
Merck
MRK
Mkt Cap376.37B
Merck & Co., Inc. is a leading pharmaceutical company with a diverse product portfolio that competes with Sihuan Pharmaceutical's offerings.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson is a healthcare giant that operates in various pharmaceutical niches, competing with Sihuan Pharmaceutical across several product lines.
Sanofi
SNY
Mkt Cap109.86B
Sanofi is a global pharmaceutical company with a wide range of products that compete with Sihuan Pharmaceutical, especially in the areas of cardiovascular and metabolic diseases.
Abbvie
ABBV
Mkt Cap468.22B
AbbVie is a research-based biopharmaceutical company with a strong presence in areas like immunology and oncology, competing with Sihuan Pharmaceutical.
Astrazeneca
AZN
Mkt Cap257.42B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with products that compete in the same therapeutic areas as Sihuan Pharmaceutical.
Bristol-Myers Squibb
BMY
Mkt Cap136.88B
Bristol Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines that compete with Sihuan Pharmaceutical.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company that engages in the research and development of pharmaceuticals and diagnostics, competing with Sihuan Pharmaceutical in several key areas.

About

SIHUAN PHARM HOLDINGS GP
Show more...
CEO
Wei Cheng Guo
Employees
2843
Country
Bermuda
ISIN
US82674Q1058

Listings

STU
DE
TEL1.STU
OTC Link
US
SHPHY
F
DE
TEL1.F
MU
DE
TEL1.MU

0 Comments

Share your thoughts

FAQ

What is Sihuan Pharmaceutical Group stock price today?▼
The current price of SHPHY is $4.40 USD — it has increased by +59.82% in the past 24 hours. Watch Sihuan Pharmaceutical Group stock price performance more closely on the chart.
What is Sihuan Pharmaceutical Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Sihuan Pharmaceutical Group stocks are traded under the ticker SHPHY.
What is Sihuan Pharmaceutical Group market cap?▼
Today Sihuan Pharmaceutical Group has the market capitalization of 41.01B
When is the next Sihuan Pharmaceutical Group earnings date?▼
Sihuan Pharmaceutical Group is going to release the next earnings report on April 01, 2027.
What were Sihuan Pharmaceutical Group earnings last quarter?▼
SHPHY earnings for the last quarter are 0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sihuan Pharmaceutical Group revenue for the last year?▼
Sihuan Pharmaceutical Group revenue for the last year amounts to 370.38M USD.
What is Sihuan Pharmaceutical Group net income for the last year?▼
SHPHY net income for the last year is 25.34M USD.
Does Sihuan Pharmaceutical Group pay dividends?▼
Yes, SHPHY dividends are paid annual. The last dividend per share was 0.06 USD. As of today, Dividend Yield (FWD)% is 1.27%.
How many employees does Sihuan Pharmaceutical Group have?▼
As of August 28, 2026, the company has 2,843 employees.
In which sector is Sihuan Pharmaceutical Group located?▼
Sihuan Pharmaceutical Group operates in the Health & Wellness sector.
When did Sihuan Pharmaceutical Group complete a stock split?▼
The last stock split for Sihuan Pharmaceutical Group was on June 05, 2014 with a ratio of 2:1.
Where is Sihuan Pharmaceutical Group headquartered?▼
Sihuan Pharmaceutical Group is headquartered in Wan Chai, Bermuda.